Allt inom Report
Nanexa publishes year-end report and Q4 report 2024
The clinical Phase I study conducted in the NEX-22 project with good results and focus on the evaluation with Novo Nordisk has provided a good starting point for 2025.
Nanexa publishes interim report for January-September 2024
Nanexas fas I-studie inom NEX-22 projektet för typ 2-diabetes har slutförts för samtliga patienter enligt plan.